Century Therapeutics IPSC
NASDAQ IPSC
$1.71 +0.06 (+3.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Non Operating Interest Expenses (2020 - 2023)

Updated

Century Therapeutics (IPSC) posted Non Operating Interest Expenses of $540,000 for FY2023.

Analysis

Century Therapeutics (IPSC) Non Operating Interest Expenses (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Century Therapeutics 308.74 Mn -195.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 136,000.00
Mar 31, 2023 404,000.00
Sep 30, 2022 373,000.00
Jun 30, 2022 330,000.00
Mar 31, 2022 314,000.00
Sep 30, 2021 322,000.00
Jun 30, 2021 318,000.00
Sep 30, 2020 59,000.00
API Access

Century Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IPSC&period=max&api_key=YOUR_API_KEY